Masonic Cancer Center, University of Minnesota

University of Minnesota Masonic Cancer Center Logo

Masonic Cancer Center of the University of Minnesota

Print this page. Mail this link to a friend.

Peter A. Argenta, M.D.

argenta

Research Program: Women's Cancer
Associate Professor, Department of Obstetrics and Gynecology

argenta@umn.edu
612-626-3111 — office

Dr. Argenta's clinical profile
(University of Minnesota Physicians website)

Research Interests

Clinical and surgical management of gynecologic malignancies. Also, the treatment and prevention of ovarian cancer, with specific interest in using antiangiogenic agents in management of metastatic tumors.

Selected Publications

Lanneau GS, Argenta PA, Lanneau MS, Riffenburgh RH, Gold MA, McMeekin DS, Webster N, Judson PL. Vulvar cancer in young women: demographic features and outcome evaluation. Am J Obstet Gynecol. 2009 Mar 13. [Epub ahead of print]

Argenta PA, Thomas SG, Judson PL, Downs LS Jr, Geller MA, Carson LF, Jonson AL, Ghebre R. A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer. Gynecol Oncol. 2009 May;113(2):205-9. Epub 2009 Feb 23.

Bookman MA, Brady MF, McGuire WP, Harper PG, Alberts DS, Friedlander M, Colombo N, Fowler JM, Argenta PA, De Geest K, Mutch DG, Burger RA, Swart AM, Trimble EL, Accario-Winslow C, Roth LM. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup. J Clin Oncol. 2009 Mar 20;27(9):1419-25. Epub 2009 Feb 17. Erratum in: J Clin Oncol. 2009 May 1;27(13):2305.

Geller MA, Argenta PA, Thomas SG, Dusenbery KE, Judson PL, Boente MP. Feasibility and morbidity of using saline filled tissue expanders to reduce radiation-induced bowel injury in patients with gynecologic malignancies. Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):93-7. Epub 2009 Feb 4.

Chura JC, Blomquist CH, Ryu HS, Argenta PA. Estrone sulfatase activity in patients with advanced ovarian cancer. Gynecol Oncol. 2009 Jan;112(1):205-9. Epub 2008 Oct 22.

Chura JC, Ryu HS, Simard M, Poirier D, Tremblay Y, Brooker DC, Blomquist CH, Argenta PA. Steroid-converting enzymes in human ovarian carcinomas. Mol Cell Endocrinol. 2009 Mar 25;301(1-2):51-8. Epub 2008 Aug 3.

Argenta PA, Ormsby RR, Downs LS Jr, Judson PL, Ghebre R, Carson LF. Routine pelvic examination during front-line chemotherapy for ovarian cancer: should it play a role? J Reprod Med. 2008 Jan;53(1):3-7.

Downs LS Jr, Judson PL, Argenta PA, Ghebre R, Geller MA, Bliss RL, Boente MP, Nahhas WA, Abu-Ghazaleh SZ, Chen MD, Carson LF. A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma. Cancer. 2008 Jan 15;112(2):331-9.

Goudge CS, Downs LS, Judson PL, Argenta PA. Stage II squamous cell carcinoma of the vagina in a patient with Bloom syndrome: a case report. J Reprod Med. 2007 Jun;52(6):557-9.

Argenta PA, Thomas S, Chura JC. Proximal-type epithelioid sarcoma vs. malignant rhabdoid tumor of the vulva: a case report, review of the literature, and an argument for consolidation. Gynecol Oncol. 2007 Oct;107(1):130-5. Epub 2007 Aug 9. Review.

Chura JC, Marushin R, Boyd A, Ghebre R, Geller MA, Argenta PA. Multimodal therapy improves survival in patients with CNS metastasis from uterine cancer: a retrospective analysis and literature review. Gynecol Oncol. 2007 Oct;107(1):79-85. Epub 2007 Jun 22. Review.

Leath CA 3rd, Huh WK, Hyde J Jr, Cohn DE, Resnick KE, Taylor NP, Powell MA, Mutch DG, Bradley WH, Geller MA, Argenta PA, Gold MA. A multi-institutional review of Detection of endometrial stromal sarcoma. Gynecol Oncol. 2007 Jun;105(3):630-4. Epub 2007 Feb 23.

Chura JC, Shukla K, Argenta PA. Brain metastasis from cervical carcinoma. Int J Gynecol Cancer. 2007 Jan-Feb;17(1):141-6.

Skubitz AP, Pambuccian SE, Argenta PA, Skubitz KM. Differential gene expression identifies subgroups of ovarian carcinoma. Transl Res. 2006 Nov;148(5):223-48.

Argenta PA, Ghebre R, Dusenbery KE, Chen MD, Judson PL, Downs LS Jr, Carson LF. Radiation therapy with concomitant and adjuvant cisplatin and paclitaxel in high-risk cervical cancer: long-term follow-up. Eur J Gynaecol Oncol. 2006;27(3):231-5.

Dusenbery KE, Potish RA, Argenta PA, Judson PL. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus. Am J Clin Oncol. 2005;28:295-300.

Argenta PA, Kubicek GJ, Dusenberry KE, Judson PL, Downs LS, Carson LF, Boente MP. Widespread lymph node metastases in a young woman with FIGO stage IA1 squamous cervical cancer. Gynecol Oncol. 2005;97:659-661.

Geller MA, Argenta P, Bradley W, Dusenbery KE, Brooker D, Downs LS Jr, Judson PL, Carson LF, Boente MP. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression. Gynecol Oncol. 2004;95:632-636.

Downs LS Jr, Judson PL, Argenta PA, Carson LF, Boente MP. A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer. Gynecol Oncol. 2004;95:347-351.

Bradley WH, Boente MP, Brooker D, Argenta PA, Downs LS, Judson PL, Carson LF. Hysteroscopy and cytology in endometrial cancer. Obstet Gynecol. 2004;104:1030-1033.